In this chapter, Dr. Mill\u27s discusses the organization of departments and connects the naming of departments to shifts in cancer medicine. He begins by explaining that Dr. Robert Bast recruited him to MD Anderson by asking the question, Would you like to build the preeminent ovarian cancer center in the world? Permission was secured from the Regents in 1994/1995 to create the Department of Molecular Oncology: Dr. Mills explains why this name was selected then talks about why the name was changed to Molecular Therapeutics after Dr. Mien Chie Hung [oral history interview] was recruited. Next, Dr. Mills explains why so many department names include the word molecular and discusses why the molecular focus was tied to a great convergence ...
In this chapter, Dr. Becker talks about taking over as Chair of Pathology where there was almost no...
Dr. Tomasovic begins this segment with comments on MD Anderson’s perceived weaknesses in basic resea...
Dr. Gehan recollects Dr. R. Lee Clark’s approach to funding, recruitment, and management and the att...
Dr. Mills begins this chapter by explaining that as cancer research evolved in the nineties, it beca...
In this chapter, Dr. Yung tells the history of the Neuro-oncology Department from 1983 to 1988. The...
Dr. Bruner begins this section with a problem she inherited as Chair of Pathology more faculty than...
In this segment, Dr. Tomasovic talks about coming to MD Anderson in 1980 as an Assistant Professor i...
Dr. Bast begins this chapter by reviewing his reasons for leaving his role as head of the cancer cen...
Dr. Arlinghaus explains the package he received when he returned to MD Anderson in 1986 to set up th...
In this chapter, Dr. Benjamin explains that he spent his first two years at MD Anderson establishing...
Dr. Mills begins this chapter on the creation of the Kleberg Institute for Molecular Markers by comm...
Dr. Becker first talks about the early phase of his research, beginning with a discussion of classi...
In this chapter, Dr. Balch explains his move to organize sections around organ based leadership, hig...
Dr. Cohen first tells the story of applying for a position at MD Anderson, noting that he wanted to ...
Dr. Arlinghaus talks about the new Department chair, Ignacio Vestula, who took over when he was aske...
In this chapter, Dr. Becker talks about taking over as Chair of Pathology where there was almost no...
Dr. Tomasovic begins this segment with comments on MD Anderson’s perceived weaknesses in basic resea...
Dr. Gehan recollects Dr. R. Lee Clark’s approach to funding, recruitment, and management and the att...
Dr. Mills begins this chapter by explaining that as cancer research evolved in the nineties, it beca...
In this chapter, Dr. Yung tells the history of the Neuro-oncology Department from 1983 to 1988. The...
Dr. Bruner begins this section with a problem she inherited as Chair of Pathology more faculty than...
In this segment, Dr. Tomasovic talks about coming to MD Anderson in 1980 as an Assistant Professor i...
Dr. Bast begins this chapter by reviewing his reasons for leaving his role as head of the cancer cen...
Dr. Arlinghaus explains the package he received when he returned to MD Anderson in 1986 to set up th...
In this chapter, Dr. Benjamin explains that he spent his first two years at MD Anderson establishing...
Dr. Mills begins this chapter on the creation of the Kleberg Institute for Molecular Markers by comm...
Dr. Becker first talks about the early phase of his research, beginning with a discussion of classi...
In this chapter, Dr. Balch explains his move to organize sections around organ based leadership, hig...
Dr. Cohen first tells the story of applying for a position at MD Anderson, noting that he wanted to ...
Dr. Arlinghaus talks about the new Department chair, Ignacio Vestula, who took over when he was aske...
In this chapter, Dr. Becker talks about taking over as Chair of Pathology where there was almost no...
Dr. Tomasovic begins this segment with comments on MD Anderson’s perceived weaknesses in basic resea...
Dr. Gehan recollects Dr. R. Lee Clark’s approach to funding, recruitment, and management and the att...